JP2004532187A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004532187A5 JP2004532187A5 JP2002559382A JP2002559382A JP2004532187A5 JP 2004532187 A5 JP2004532187 A5 JP 2004532187A5 JP 2002559382 A JP2002559382 A JP 2002559382A JP 2002559382 A JP2002559382 A JP 2002559382A JP 2004532187 A5 JP2004532187 A5 JP 2004532187A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- compound
- amino
- trifluoromethyl
- dichlorophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- -1 cardibosi Chemical group 0.000 claims 39
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 26
- 150000001875 compounds Chemical class 0.000 claims 14
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 7
- VVNCNSJFMMFHPL-VKHMYHEASA-N D-penicillamine Chemical group CC(C)(S)[C@@H](N)C(O)=O VVNCNSJFMMFHPL-VKHMYHEASA-N 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000003342 alkenyl group Chemical group 0.000 claims 5
- 125000000304 alkynyl group Chemical group 0.000 claims 5
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 5
- 229910052760 oxygen Inorganic materials 0.000 claims 5
- 229910052717 sulfur Inorganic materials 0.000 claims 5
- 125000005843 halogen group Chemical group 0.000 claims 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 4
- 229920006395 saturated elastomer Polymers 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 claims 2
- 125000002861 (C1-C4) alkanoyl group Chemical group 0.000 claims 2
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 claims 2
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims 2
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 claims 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims 2
- 229940126657 Compound 17 Drugs 0.000 claims 2
- 102000001493 Cyclophilins Human genes 0.000 claims 2
- 108010068682 Cyclophilins Proteins 0.000 claims 2
- 102000000521 Immunophilins Human genes 0.000 claims 2
- 108010016648 Immunophilins Proteins 0.000 claims 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims 2
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 claims 2
- 125000003302 alkenyloxy group Chemical group 0.000 claims 2
- 125000003282 alkyl amino group Chemical group 0.000 claims 2
- 125000005100 aryl amino carbonyl group Chemical group 0.000 claims 2
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 claims 2
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 claims 2
- 125000002619 bicyclic group Chemical group 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 229940126142 compound 16 Drugs 0.000 claims 2
- 229940125833 compound 23 Drugs 0.000 claims 2
- 229940125961 compound 24 Drugs 0.000 claims 2
- 229940125846 compound 25 Drugs 0.000 claims 2
- 125000004802 cyanophenyl group Chemical group 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 230000003647 oxidation Effects 0.000 claims 2
- 238000007254 oxidation reaction Methods 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000000165 tricyclic carbocycle group Chemical group 0.000 claims 2
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 claims 1
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 claims 1
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 claims 1
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 claims 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 claims 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 claims 1
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 claims 1
- YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 claims 1
- VIJSPAIQWVPKQZ-BLECARSGSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-4,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O VIJSPAIQWVPKQZ-BLECARSGSA-N 0.000 claims 1
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 claims 1
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 claims 1
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 claims 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 claims 1
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 claims 1
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 claims 1
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 claims 1
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 claims 1
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims 1
- JHZKGLRQCPEORL-UHFFFAOYSA-N 1-(3,5-dichlorophenyl)-3-[3-[(3,5-dichlorophenyl)carbamothioylamino]-4-(3,5-dimethyl-1h-pyrazol-4-yl)phenyl]thiourea Chemical compound CC1=NNC(C)=C1C(C(=C1)NC(=S)NC=2C=C(Cl)C=C(Cl)C=2)=CC=C1NC(=S)NC1=CC(Cl)=CC(Cl)=C1 JHZKGLRQCPEORL-UHFFFAOYSA-N 0.000 claims 1
- HPEDGMSNQGELJW-UHFFFAOYSA-N 1-(3,5-dichlorophenyl)-3-[3-[(3,5-dichlorophenyl)carbamothioylamino]-5-(pyridin-2-ylamino)phenyl]thiourea Chemical compound ClC1=CC(Cl)=CC(NC(=S)NC=2C=C(NC=3N=CC=CC=3)C=C(NC(=S)NC=3C=C(Cl)C=C(Cl)C=3)C=2)=C1 HPEDGMSNQGELJW-UHFFFAOYSA-N 0.000 claims 1
- JIWPWVSYPFVUEH-UHFFFAOYSA-N 1-(3,5-dichlorophenyl)-3-[3-[(3,5-dichlorophenyl)methoxy]-4-methoxyphenyl]urea Chemical compound C1=C(OCC=2C=C(Cl)C=C(Cl)C=2)C(OC)=CC=C1NC(=O)NC1=CC(Cl)=CC(Cl)=C1 JIWPWVSYPFVUEH-UHFFFAOYSA-N 0.000 claims 1
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 claims 1
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 claims 1
- JOFFDFFLNOZGPI-UHFFFAOYSA-N 1-[3-[(3,5-dichlorophenoxy)methyl]-4-methoxyphenyl]-3-(3,5-dichlorophenyl)thiourea Chemical compound C1=C(COC=2C=C(Cl)C=C(Cl)C=2)C(OC)=CC=C1NC(=S)NC1=CC(Cl)=CC(Cl)=C1 JOFFDFFLNOZGPI-UHFFFAOYSA-N 0.000 claims 1
- FAFAURBWCYQOAI-UHFFFAOYSA-N 1-[3-amino-5-[(1,3-dioxoisoindol-2-yl)methyl]phenyl]-3-(3,5-dichlorophenyl)thiourea Chemical compound C=1C(N)=CC(CN2C(C3=CC=CC=C3C2=O)=O)=CC=1NC(=S)NC1=CC(Cl)=CC(Cl)=C1 FAFAURBWCYQOAI-UHFFFAOYSA-N 0.000 claims 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 claims 1
- HVHOOAFUGQWZRX-UHFFFAOYSA-N 1-n,3-n-bis(3-cyanophenyl)-5-[[4-(2-cyanophenyl)phenyl]methoxy]benzene-1,3-dicarboxamide Chemical compound C=1C(OCC=2C=CC(=CC=2)C=2C(=CC=CC=2)C#N)=CC(C(=O)NC=2C=C(C=CC=2)C#N)=CC=1C(=O)NC1=CC=CC(C#N)=C1 HVHOOAFUGQWZRX-UHFFFAOYSA-N 0.000 claims 1
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 claims 1
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 claims 1
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 claims 1
- XQEDPOPUYACQHT-UHFFFAOYSA-N 3,5-bis(phenylmethoxy)-n-[3-(trifluoromethyl)phenyl]benzamide Chemical compound FC(F)(F)C1=CC=CC(NC(=O)C=2C=C(OCC=3C=CC=CC=3)C=C(OCC=3C=CC=CC=3)C=2)=C1 XQEDPOPUYACQHT-UHFFFAOYSA-N 0.000 claims 1
- BGAJNPLDJJBRHK-UHFFFAOYSA-N 3-[2-[5-(3-chloro-4-propan-2-yloxyphenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-6,7-dihydro-4h-pyrazolo[4,3-c]pyridin-5-yl]propanoic acid Chemical compound C1=C(Cl)C(OC(C)C)=CC=C1C1=NN=C(N2C(=C3CN(CCC(O)=O)CCC3=N2)C)S1 BGAJNPLDJJBRHK-UHFFFAOYSA-N 0.000 claims 1
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims 1
- STPZLKGANBNWBQ-UHFFFAOYSA-N 5-(naphthalen-2-ylmethoxy)-1-n,3-n-bis[3-(trifluoromethyl)phenyl]benzene-1,3-dicarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC(=O)C=2C=C(C=C(OCC=3C=C4C=CC=CC4=CC=3)C=2)C(=O)NC=2C=C(C=CC=2)C(F)(F)F)=C1 STPZLKGANBNWBQ-UHFFFAOYSA-N 0.000 claims 1
- DATYDMBUQCSPCN-UHFFFAOYSA-N 5-[(3,4-dichlorophenoxy)methyl]-1-n,3-n-bis(3,5-dichlorophenyl)benzene-1,3-dicarboxamide Chemical compound ClC1=CC(Cl)=CC(NC(=O)C=2C=C(C=C(COC=3C=C(Cl)C(Cl)=CC=3)C=2)C(=O)NC=2C=C(Cl)C=C(Cl)C=2)=C1 DATYDMBUQCSPCN-UHFFFAOYSA-N 0.000 claims 1
- WHDXBYKMDNYEGD-UHFFFAOYSA-N 5-[(3,4-dichlorophenoxy)methyl]-1-n,3-n-bis[2-(3,4-dichlorophenyl)ethyl]benzene-1,3-dicarboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1CCNC(=O)C1=CC(COC=2C=C(Cl)C(Cl)=CC=2)=CC(C(=O)NCCC=2C=C(Cl)C(Cl)=CC=2)=C1 WHDXBYKMDNYEGD-UHFFFAOYSA-N 0.000 claims 1
- KRUKPNFOPMFLEJ-UHFFFAOYSA-N 5-[(3,4-dichlorophenyl)methoxy]-1-n,3-n-bis(3,4,5-trichlorophenyl)benzene-1,3-dicarboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1COC1=CC(C(=O)NC=2C=C(Cl)C(Cl)=C(Cl)C=2)=CC(C(=O)NC=2C=C(Cl)C(Cl)=C(Cl)C=2)=C1 KRUKPNFOPMFLEJ-UHFFFAOYSA-N 0.000 claims 1
- RAIWKUFHBNUZJQ-UHFFFAOYSA-N 5-[2-(3,4-dichloroanilino)-2-oxo-1-phenylethoxy]-1-n,3-n-bis(3,4-dichlorophenyl)benzene-1,3-dicarboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1NC(=O)C(C=1C=CC=CC=1)OC1=CC(C(=O)NC=2C=C(Cl)C(Cl)=CC=2)=CC(C(=O)NC=2C=C(Cl)C(Cl)=CC=2)=C1 RAIWKUFHBNUZJQ-UHFFFAOYSA-N 0.000 claims 1
- AKZYHPXZLIGIJR-UHFFFAOYSA-N 5-hydroxy-1-n,3-n-bis[3-(trifluoromethyl)phenyl]benzene-1,3-dicarboxamide Chemical compound C=1C(O)=CC(C(=O)NC=2C=C(C=CC=2)C(F)(F)F)=CC=1C(=O)NC1=CC=CC(C(F)(F)F)=C1 AKZYHPXZLIGIJR-UHFFFAOYSA-N 0.000 claims 1
- HCCNBKFJYUWLEX-UHFFFAOYSA-N 7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)-3-(pyrazin-2-ylmethylamino)pyrido[3,4-b]pyrazin-2-one Chemical compound O=C1N(CCOCCC)C2=CC(C=3C=NC(OC)=CC=3)=NC=C2N=C1NCC1=CN=CC=N1 HCCNBKFJYUWLEX-UHFFFAOYSA-N 0.000 claims 1
- 201000004384 Alopecia Diseases 0.000 claims 1
- 125000004399 C1-C4 alkenyl group Chemical group 0.000 claims 1
- BQXUPNKLZNSUMC-YUQWMIPFSA-N CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 Chemical compound CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 BQXUPNKLZNSUMC-YUQWMIPFSA-N 0.000 claims 1
- 229940126639 Compound 33 Drugs 0.000 claims 1
- 229940127007 Compound 39 Drugs 0.000 claims 1
- 208000001840 Dandruff Diseases 0.000 claims 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 claims 1
- 241001674048 Phthiraptera Species 0.000 claims 1
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 claims 1
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 claims 1
- SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 claims 1
- PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 claims 1
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 125000005115 alkyl carbamoyl group Chemical group 0.000 claims 1
- 229940035674 anesthetics Drugs 0.000 claims 1
- 239000000058 anti acne agent Substances 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000001142 anti-diarrhea Effects 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 229940124340 antiacne agent Drugs 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 229940125714 antidiarrheal agent Drugs 0.000 claims 1
- 239000003793 antidiarrheal agent Substances 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 239000002585 base Substances 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 1
- 239000003139 biocide Substances 0.000 claims 1
- 230000000903 blocking effect Effects 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 229940125904 compound 1 Drugs 0.000 claims 1
- 229940125773 compound 10 Drugs 0.000 claims 1
- 229940125797 compound 12 Drugs 0.000 claims 1
- 229940126543 compound 14 Drugs 0.000 claims 1
- 229940125758 compound 15 Drugs 0.000 claims 1
- 229940125782 compound 2 Drugs 0.000 claims 1
- 229940125810 compound 20 Drugs 0.000 claims 1
- 229940126086 compound 21 Drugs 0.000 claims 1
- 229940126208 compound 22 Drugs 0.000 claims 1
- 229940125851 compound 27 Drugs 0.000 claims 1
- 229940127204 compound 29 Drugs 0.000 claims 1
- 229940126214 compound 3 Drugs 0.000 claims 1
- 229940125877 compound 31 Drugs 0.000 claims 1
- 229940125878 compound 36 Drugs 0.000 claims 1
- 229940125807 compound 37 Drugs 0.000 claims 1
- 229940127573 compound 38 Drugs 0.000 claims 1
- 229940126540 compound 41 Drugs 0.000 claims 1
- 229940125936 compound 42 Drugs 0.000 claims 1
- 229940125844 compound 46 Drugs 0.000 claims 1
- 229940127271 compound 49 Drugs 0.000 claims 1
- 229940125898 compound 5 Drugs 0.000 claims 1
- 229940126545 compound 53 Drugs 0.000 claims 1
- 210000004748 cultured cell Anatomy 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 239000003193 general anesthetic agent Substances 0.000 claims 1
- 239000007952 growth promoter Substances 0.000 claims 1
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 claims 1
- 239000000118 hair dye Substances 0.000 claims 1
- 230000003779 hair growth Effects 0.000 claims 1
- 208000024963 hair loss Diseases 0.000 claims 1
- 230000003676 hair loss Effects 0.000 claims 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 claims 1
- 239000003410 keratolytic agent Substances 0.000 claims 1
- RENRQMCACQEWFC-UGKGYDQZSA-N lnp023 Chemical compound C1([C@H]2N(CC=3C=4C=CNC=4C(C)=CC=3OC)CC[C@@H](C2)OCC)=CC=C(C(O)=O)C=C1 RENRQMCACQEWFC-UGKGYDQZSA-N 0.000 claims 1
- BGFSWGKCECGNQF-UHFFFAOYSA-N methyl 3-[3,5-bis[(3,5-dichlorophenyl)carbamoylamino]phenyl]propanoate Chemical compound C=1C(NC(=O)NC=2C=C(Cl)C=C(Cl)C=2)=CC(CCC(=O)OC)=CC=1NC(=O)NC1=CC(Cl)=CC(Cl)=C1 BGFSWGKCECGNQF-UHFFFAOYSA-N 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims 1
- 210000003470 mitochondria Anatomy 0.000 claims 1
- 230000002438 mitochondrial effect Effects 0.000 claims 1
- UIMXXUKNTRPASK-UHFFFAOYSA-N n-(3,5-dichlorophenyl)formamide Chemical compound ClC1=CC(Cl)=CC(NC=O)=C1 UIMXXUKNTRPASK-UHFFFAOYSA-N 0.000 claims 1
- SCZCRWSFNCVBBD-UHFFFAOYSA-N n-(3-benzoyl-4-chlorophenyl)-n-(3,5-dichlorophenyl)formamide Chemical compound ClC1=CC(Cl)=CC(N(C=O)C=2C=C(C(Cl)=CC=2)C(=O)C=2C=CC=CC=2)=C1 SCZCRWSFNCVBBD-UHFFFAOYSA-N 0.000 claims 1
- QANWSKQHACYYSF-UHFFFAOYSA-N n-[2-bromo-5-(naphthalen-1-ylmethoxy)phenyl]-n-[3-(trifluoromethyl)phenyl]formamide Chemical compound FC(F)(F)C1=CC=CC(N(C=O)C=2C(=CC=C(OCC=3C4=CC=CC=C4C=CC=3)C=2)Br)=C1 QANWSKQHACYYSF-UHFFFAOYSA-N 0.000 claims 1
- NXEQUZVZZFQGQG-UHFFFAOYSA-N n-[3-[(1,3-dioxoisoindol-2-yl)methyl]-5-[n-formyl-3-(trifluoromethyl)anilino]phenyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC=CC(N(C=O)C=2C=C(NC(=O)C=3C=C(C=CC=3)C(F)(F)F)C=C(CN3C(C4=CC=CC=C4C3=O)=O)C=2)=C1 NXEQUZVZZFQGQG-UHFFFAOYSA-N 0.000 claims 1
- UKUFSVUBPRMVQV-UHFFFAOYSA-N n-[3-[bis[(3,5-dichlorophenyl)sulfonyl]amino]-4-bromophenyl]-n-(3,5-dichloroanilino)formamide Chemical compound ClC1=CC(Cl)=CC(NN(C=O)C=2C=C(C(Br)=CC=2)N(S(=O)(=O)C=2C=C(Cl)C=C(Cl)C=2)S(=O)(=O)C=2C=C(Cl)C=C(Cl)C=2)=C1 UKUFSVUBPRMVQV-UHFFFAOYSA-N 0.000 claims 1
- XUCFMLORDYOKDI-UHFFFAOYSA-N n-[3-[n-formyl-3-(trifluoromethyl)anilino]-5-[(naphthalen-1-ylmethylamino)methyl]phenyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC=CC(N(C=O)C=2C=C(NC(=O)C=3C=C(C=CC=3)C(F)(F)F)C=C(CNCC=3C4=CC=CC=C4C=CC=3)C=2)=C1 XUCFMLORDYOKDI-UHFFFAOYSA-N 0.000 claims 1
- PIBVWJNOHQENBR-UHFFFAOYSA-N n-[4-methoxy-3-(naphthalen-1-ylmethoxy)phenyl]-2,2-diphenylacetamide Chemical compound C1=C(OCC=2C3=CC=CC=C3C=CC=2)C(OC)=CC=C1NC(=O)C(C=1C=CC=CC=1)C1=CC=CC=C1 PIBVWJNOHQENBR-UHFFFAOYSA-N 0.000 claims 1
- GLOWRCUXYWWMIT-UHFFFAOYSA-N n-[4-methoxy-3-(naphthalen-1-ylmethoxy)phenyl]-2-naphthalen-2-ylacetamide Chemical compound C1=CC=C2C(COC3=CC(NC(=O)CC=4C=C5C=CC=CC5=CC=4)=CC=C3OC)=CC=CC2=C1 GLOWRCUXYWWMIT-UHFFFAOYSA-N 0.000 claims 1
- QSGBTWHYIFNSGX-UHFFFAOYSA-N n-[4-methoxy-3-(naphthalen-1-ylmethoxy)phenyl]-n-naphthalen-1-ylformamide Chemical compound C1=CC=C2C(N(C=O)C3=CC=C(C(=C3)OCC=3C4=CC=CC=C4C=CC=3)OC)=CC=CC2=C1 QSGBTWHYIFNSGX-UHFFFAOYSA-N 0.000 claims 1
- GALHUQUCWUONEH-UHFFFAOYSA-N n-[[3-[(3,5-dichlorophenoxy)methyl]-4-methoxyphenyl]carbamothioyl]benzamide Chemical compound C1=C(COC=2C=C(Cl)C=C(Cl)C=2)C(OC)=CC=C1NC(=S)NC(=O)C1=CC=CC=C1 GALHUQUCWUONEH-UHFFFAOYSA-N 0.000 claims 1
- IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 claims 1
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 claims 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 1
- 230000008823 permeabilization Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 1
- 239000011148 porous material Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26370301P | 2001-01-25 | 2001-01-25 | |
| US29196501P | 2001-05-21 | 2001-05-21 | |
| PCT/US2002/002538 WO2002059080A2 (en) | 2001-01-25 | 2002-01-25 | Trisubstituted carbocyclic cyclophilin binding compounds and their use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004532187A JP2004532187A (ja) | 2004-10-21 |
| JP2004532187A5 true JP2004532187A5 (https=) | 2005-12-22 |
Family
ID=26950004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002559382A Withdrawn JP2004532187A (ja) | 2001-01-25 | 2002-01-25 | 三置換カルボサイクリックサイクロフィリン結合化合物とその用途 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6656971B2 (https=) |
| EP (1) | EP1360173A2 (https=) |
| JP (1) | JP2004532187A (https=) |
| CA (1) | CA2435829A1 (https=) |
| MX (1) | MXPA03006666A (https=) |
| WO (1) | WO2002059080A2 (https=) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| ATE538794T1 (de) | 1999-01-13 | 2012-01-15 | Bayer Healthcare Llc | Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer |
| TWI297335B (en) * | 2001-07-10 | 2008-06-01 | Synta Pharmaceuticals Corp | Taxol enhancer compounds |
| TWI332943B (en) * | 2001-07-10 | 2010-11-11 | Synta Pharmaceuticals Corp | Taxol enhancer compounds |
| US6924312B2 (en) * | 2001-07-10 | 2005-08-02 | Synta Pharmaceuticals Corp. | Taxol enhancer compounds |
| TWI252847B (en) * | 2001-07-10 | 2006-04-11 | Synta Pharmaceuticals Corp | Synthesis of taxol enhancers |
| EP1430032A2 (en) * | 2001-09-24 | 2004-06-23 | Elan Pharmaceuticals, Inc. | Substituted amides for the treatment of neurological disorders |
| MXPA04007832A (es) | 2002-02-11 | 2005-09-08 | Bayer Pharmaceuticals Corp | Aril-ureas con actividad inhibitoria de angiogenesis. |
| EP2399903A1 (en) | 2002-05-24 | 2011-12-28 | Millennium Pharmaceuticals, Inc. | Ccr9 inhibitors and methods of use thereof |
| EP1402888A1 (en) * | 2002-09-18 | 2004-03-31 | Jerini AG | The use of substituted carbocyclic compounds as rotamases inhibitors |
| US6939885B2 (en) | 2002-11-18 | 2005-09-06 | Chemocentryx | Aryl sulfonamides |
| US7741519B2 (en) | 2007-04-23 | 2010-06-22 | Chemocentryx, Inc. | Bis-aryl sulfonamides |
| US7420055B2 (en) | 2002-11-18 | 2008-09-02 | Chemocentryx, Inc. | Aryl sulfonamides |
| US7227035B2 (en) | 2002-11-18 | 2007-06-05 | Chemocentryx | Bis-aryl sulfonamides |
| WO2004052962A1 (ja) * | 2002-12-11 | 2004-06-24 | Nissan Chemical Industries, Ltd. | 新規なジアミノベンゼン誘導体、それを用いたポリイミド前駆体およびポリイミド、並びに液晶配向処理剤 |
| CA2511970C (en) * | 2003-01-14 | 2012-06-26 | Cytokinetics, Inc. | Urea derivatives useful in the treatment of heart failure |
| TWI330079B (en) * | 2003-01-15 | 2010-09-11 | Synta Pharmaceuticals Corp | Treatment for cancers |
| SI2656854T1 (sl) | 2003-02-04 | 2015-09-30 | Cornell Research Foundation, Inc. | Uporabe aromatsko-kationskega peptida |
| US7557129B2 (en) | 2003-02-28 | 2009-07-07 | Bayer Healthcare Llc | Cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| WO2004113274A2 (en) | 2003-05-20 | 2004-12-29 | Bayer Pharmaceuticals Corporation | Diaryl ureas with kinase inhibiting activity |
| EA010485B1 (ru) | 2003-07-23 | 2008-10-30 | Байер Фамэсьютиклс Копэрейшн | Производное n,n'-дифенилмочевины, фармацевтическая композиция (варианты) и способ лечения и предупреждения заболеваний и состояний с его использованием (варианты) |
| TW200510305A (en) * | 2003-07-25 | 2005-03-16 | Wyeth Corp | Process for the preparation of CPLA2 inhibitors |
| BRPI0415179A (pt) | 2003-10-07 | 2006-11-28 | Renovis Inc | derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas |
| TW200529812A (en) * | 2003-12-26 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Benzamide derivatives |
| CA2851972C (en) | 2004-01-23 | 2015-06-23 | Cornell Research Foundation, Inc. | Methods for reducing oxidative damage |
| JP5080970B2 (ja) | 2004-06-17 | 2012-11-21 | サイトキネティクス・インコーポレーテッド | 心疾患を治療するための置換尿素誘導体 |
| CN1993318B (zh) | 2004-06-23 | 2012-10-03 | Synta医药公司 | 用于治疗癌症的双（硫代-酰肼酰胺）盐 |
| US7176222B2 (en) | 2004-07-27 | 2007-02-13 | Cytokinetics, Inc. | Syntheses of ureas |
| JP5204489B2 (ja) * | 2004-11-19 | 2013-06-05 | シンタ ファーマスーティカルズ コーポレイション | Ｈｓｐ７０発現を増加するためのビス（チオ‐ヒドラジドアミド） |
| BRPI0606365A2 (pt) * | 2005-02-28 | 2017-06-27 | Renovis Inc | composto ou um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo e estereoisômeros e tautômeros do mesmo, composição farmacêutica, métodos para prevenir, tratar, melhorar ou controlar uma doença ou condição e para preparar um composto, uso de um composto ou um sal, solvato ou composição farmaceuticamente aceitável do mesmo, método de tratamento de um mamífero, e, combinação |
| US7576099B2 (en) * | 2005-02-28 | 2009-08-18 | Renovis, Inc. | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| DE102005015255A1 (de) * | 2005-04-04 | 2006-10-05 | Merck Patent Gmbh | Acylhydrazide |
| US7312181B2 (en) | 2005-04-08 | 2007-12-25 | Cropsolution, Inc. | Acylated thiosemicarbazides as herbicides |
| WO2006113695A1 (en) * | 2005-04-15 | 2006-10-26 | Synta Pharmaceuticals Corp. | Combination cancer therapy with bis(thiohydrazide) amide compounds |
| KR20080008399A (ko) | 2005-05-16 | 2008-01-23 | 신타 파마슈티칼스 코프. | 비스(티오-히드라지드 아미드) 염의 합성 방법 |
| US7538223B2 (en) * | 2005-08-04 | 2009-05-26 | Cytokinetics, Inc. | Compounds, compositions and methods |
| KR20080035642A (ko) * | 2005-08-16 | 2008-04-23 | 신타 파마슈티칼스 코프. | 비스(티오-히드라지드 아미드) 제제 |
| TW200808321A (en) | 2005-12-15 | 2008-02-16 | Cytokinetics Inc | Certain chemical entities, compositions and methods |
| US7825120B2 (en) * | 2005-12-15 | 2010-11-02 | Cytokinetics, Inc. | Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas |
| US20070208000A1 (en) * | 2005-12-15 | 2007-09-06 | Morgan Bradley P | Certain chemical entities, compositions and methods |
| US20070197505A1 (en) * | 2005-12-15 | 2007-08-23 | Morgan Bradley P | Certain chemical entities, compositions and methods |
| EP1959962A2 (en) | 2005-12-16 | 2008-08-27 | Cytokinetics, Inc. | Certain chemical entities, compositions, and methods |
| EP1962852B1 (en) * | 2005-12-19 | 2017-01-25 | Cytokinetics, Inc. | Compounds, compositions and methods |
| TWI440632B (zh) * | 2006-08-21 | 2014-06-11 | Synta Pharmaceuticals Corp | 用於治療增生性疾病的化合物 |
| JP2010502616A (ja) * | 2006-08-31 | 2010-01-28 | シンタ ファーマシューティカルズ コーポレーション | 癌を治療するためのビス（チオヒドラジドアミド）の組み合わせ |
| US7645904B2 (en) * | 2006-09-15 | 2010-01-12 | Synta Pharmaceuticals Corp. | Purification of bis(thiohydrazide amides) |
| JP5470653B2 (ja) * | 2006-10-26 | 2014-04-16 | アムジエン・インコーポレーテツド | カルシウム受容体調節剤 |
| EP2167688A4 (en) * | 2007-06-12 | 2010-07-28 | Univ Case Western Reserve | TARGETED CELL DEATH |
| DE102008060549A1 (de) | 2008-12-04 | 2010-06-10 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung |
| US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
| KR101558222B1 (ko) | 2012-09-12 | 2015-10-12 | 경희대학교 산학협력단 | 사이클로필린 ａ를 포함하는 탈모 방지 및 발모 개선을 위한 조성물 |
| SG11201604611SA (en) | 2013-12-18 | 2016-07-28 | Glaxosmithkline Ip Dev Ltd | Nrf2 regulators |
| WO2016203401A1 (en) | 2015-06-15 | 2016-12-22 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 regulators |
| LT3307739T (lt) | 2015-06-15 | 2021-03-10 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 reguliatoriai |
| US10364256B2 (en) | 2015-10-06 | 2019-07-30 | Glaxosmithkline Intellectual Property Development Limited | Biaryl pyrazoles as NRF2 regulators |
| WO2017157873A1 (en) | 2016-03-17 | 2017-09-21 | F. Hoffmann-La Roche Ag | 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar |
| WO2018062954A1 (ko) * | 2016-09-30 | 2018-04-05 | (주)나노믹스 | 사이클로필린 기능 저해제 및 사용방법 |
| GB2595502B (en) * | 2020-05-28 | 2023-01-11 | Chopra Sunil | Compounds, compositions and methods for the treatment or prevention of hair loss |
| AU2023228095A1 (en) | 2022-03-02 | 2024-08-15 | Horizon Therapeutics Ireland Dac | Process of making a crystalline edg-2 receptor antagonist |
Family Cites Families (148)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2328490A (en) | 1939-09-04 | 1943-08-31 | Winthrop Chem Co Inc | Diphenylsulphone derivative |
| US2333552A (en) | 1939-09-04 | 1943-11-02 | Winthrop Chem Co Inc | Process of manufacturing diphenylsulphone derivatives and product obtainable by suchprocess |
| US2395484A (en) | 1943-04-16 | 1946-02-26 | Du Pont | Bis sulphonamides of naphthol sulphonyl chlorides with aromatic diamines |
| US2635535A (en) | 1946-01-31 | 1953-04-21 | Du Pont | Mordanting |
| US2593563A (en) * | 1949-05-02 | 1952-04-22 | Max N Huffman | Phloroglucinol derivatives |
| US2714613A (en) | 1953-10-08 | 1955-08-02 | Ciba Pharm Prod Inc | Di-(p-substituted phenyl)-thioureas |
| CH459172A (de) * | 1961-09-11 | 1968-07-15 | Wander Ag Dr A | Verfahren zur Herstellung mehrbasischer Verbindungen |
| US3872157A (en) | 1967-10-23 | 1975-03-18 | Stauffer Chemical Co | Substituted anilide carbamates |
| US3821200A (en) | 1968-01-16 | 1974-06-28 | Toms River Chemical Corp | Nitrodiphenylamine dyestuffs |
| DE1914999A1 (de) | 1968-04-04 | 1969-11-06 | Ciba Geigy | Neue Guanylhydrazone und Verfahren zu ihrer Herstellung |
| US3941581A (en) | 1970-03-16 | 1976-03-02 | Stauffer Chemical Company | Meta-bis anilide derivatives and their utility as herbicides |
| US3867426A (en) | 1970-10-02 | 1975-02-18 | Monsanto Co | Herbicidal meta-bifunctional benzenes |
| US3876797A (en) * | 1970-12-09 | 1975-04-08 | Aldrich Chem Co Inc | Di-substituted ' -phenethylcarbamic acid esters in the treatment of parkinsonism |
| US3829463A (en) | 1971-05-19 | 1974-08-13 | Upjohn Co | Oxime substituted carbanilates |
| US3829464A (en) | 1971-05-19 | 1974-08-13 | Upjohn Co | Benzaldoxime-meta-carbamates |
| US3981914A (en) | 1971-08-03 | 1976-09-21 | Minnesota Mining And Manufacturing Company | N-alkylsulfonylperfluoroalkanesulfonanilides |
| US4028093A (en) | 1971-09-09 | 1977-06-07 | Stauffer Chemical Company | Meta-bis anilide derivatives and their utility as herbicides |
| US3937729A (en) | 1971-09-15 | 1976-02-10 | Stauffer Chemical Company | Meta-bis anilide derivatives and their utility as herbicides |
| US3880642A (en) | 1971-11-12 | 1975-04-29 | Stauffer Chemical Co | Bis-anilide compositions as algicidal agents |
| DE2334607A1 (de) | 1973-07-07 | 1975-01-30 | Bayer Ag | Sulfonyloxyphenylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung als herbizide |
| US4238503A (en) | 1974-02-19 | 1980-12-09 | Stauffer Chemical Company | Anilide urea biocides |
| PH13853A (en) | 1975-01-13 | 1980-10-22 | Stauffer Chemical Co | Substituted thiomethylurea herbicides |
| US4031127A (en) | 1975-08-06 | 1977-06-21 | Eastman Kodak Company | Acyl hydrazino thiourea derivatives as photographic nucleating agents |
| US4044147A (en) | 1976-05-26 | 1977-08-23 | Pfizer Inc. | N-(acyl)-p-amino-N'-(monosubstituted)-benzamide anti-ulcer agents |
| US4041070A (en) | 1976-07-14 | 1977-08-09 | American Cyanamid Company | Tetrahydro-4-imino-1-naphthylureas |
| DE2703838A1 (de) | 1977-01-31 | 1978-08-10 | Basf Ag | Diurethane |
| JPS5937492B2 (ja) | 1977-11-28 | 1984-09-10 | 富士写真フイルム株式会社 | 直接ポジハロゲン化銀感光材料 |
| IL56012A (en) | 1977-11-29 | 1983-07-31 | Takeda Chemical Industries Ltd | N-(2-fluoro-4-bromo(or chloro)phenyl)-3,4,5,6-tetrahydrophthalamic acid derivatives,their preparation,and herbicidal compositions comprising them |
| JPS5930257B2 (ja) | 1978-04-06 | 1984-07-26 | 富士写真フイルム株式会社 | 直接ポジハロゲン化銀感光材料 |
| JPS5533439A (en) | 1978-08-31 | 1980-03-08 | Konishiroku Photo Ind Co Ltd | 2-sulfamoyl-5-sulfamido-1-naphthol |
| DE2844806A1 (de) | 1978-10-11 | 1980-04-24 | Schering Ag | Carbanilsaeure- eckige klammer auf 3-(alkylcarbonylamino)-phenyl eckige klammer zu -ester, verfahren zur herstellung dieser verbindungen sowie diese enthaltendes herbizides mittel |
| JPS5931691B2 (ja) | 1978-11-30 | 1984-08-03 | 富士写真フイルム株式会社 | 直接ポジハロゲン化銀感光材料 |
| DE2909198A1 (de) | 1979-03-08 | 1980-09-11 | Basf Ag | Phenylcarbamidsaeurechloride und verfahren zu ihrer herstellung |
| DE2921216A1 (de) | 1979-05-25 | 1980-12-04 | Teschemacher Hansjoerg | Pharmakologisch aktive peptide |
| DE2928485A1 (de) | 1979-07-14 | 1981-01-29 | Bayer Ag | Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen |
| CH649078A5 (de) | 1980-01-25 | 1985-04-30 | Reanal Finomvegyszergyar | Verfahren zur herstellung von n-mono- oder disubstituierten n-aryl-harnstoff-derivaten. |
| US4373017A (en) | 1980-03-05 | 1983-02-08 | Konishiroku Photo Industry Co., Ltd. | Photosensitive compound and photosensitive material containing it |
| IL62973A0 (en) | 1980-06-02 | 1981-07-31 | Basf Ag | Aralkylphenylureas,their manufacture and their use as herbicides |
| HU185294B (en) | 1980-12-29 | 1984-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing substituted urea derivatives |
| DE3260468D1 (en) | 1981-01-09 | 1984-09-06 | Sandoz Ag | Novel cyclosporins |
| US4468405A (en) | 1981-07-30 | 1984-08-28 | The Dow Chemical Company | Substituted N-aroyl N'-phenyl urea compounds |
| JPS58121148A (ja) | 1982-01-11 | 1983-07-19 | Olympus Optical Co Ltd | 光学的情報記録再生装置 |
| US4473579A (en) | 1982-01-26 | 1984-09-25 | American Cyanamid Company | Antiatherosclerotic tetrasubstituted ureas and thioureas |
| US4387106A (en) | 1982-01-26 | 1983-06-07 | American Cyanamid Company | Method of treating atherosclerosis with di(aralkyl)ureas and di(aralkyl)thioureas |
| US4623662A (en) | 1985-05-23 | 1986-11-18 | American Cyanamid Company | Antiatherosclerotic ureas and thioureas |
| DE3217619A1 (de) | 1982-05-11 | 1983-11-17 | Bayer Ag, 5090 Leverkusen | 2,4-dihalogenbenzoyl-(thio)harnstoffe, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel |
| US5003106A (en) | 1983-07-19 | 1991-03-26 | American Cyanamid Company | Antiatherosclerotic ureas and thioureas |
| US4544654A (en) | 1984-03-20 | 1985-10-01 | Schering A.G. | Substituted sulfonamidobenzamides, antiarrhythmic agents and compositions thereof |
| US5288914A (en) | 1984-08-27 | 1994-02-22 | The Dow Chemical Company | Poly(arylcyclobutenes) |
| US4608082A (en) | 1985-02-19 | 1986-08-26 | Union Carbide Corporation | Herbicidal cycloalkenyl acetamides |
| EP0194972B1 (en) | 1985-03-11 | 1992-07-29 | Sandoz Ag | Novel cyclosporins |
| SE447579B (sv) | 1985-04-01 | 1986-11-24 | Biopool Ab | Solubiliserbar, fibrinbaserad komposition och anvendning av kompositionen vid bestemning av fibrinolysparametrar |
| US5462927A (en) | 1985-04-30 | 1995-10-31 | The Administrators Of The Tulane Educational Fund | Peptides aiding nerve regeneration |
| US5057610A (en) | 1986-04-25 | 1991-10-15 | Ciba-Geigy Corporation | Compositions stabilized with substituted amino carbamates |
| DE3636190A1 (de) | 1986-10-24 | 1988-04-28 | Bayer Ag | Verfahren zur herstellung von n,n-diaryl-harnstoffen |
| US4764503A (en) | 1986-11-19 | 1988-08-16 | Sandoz Ltd. | Novel cyclosporins |
| US5015644A (en) | 1987-06-02 | 1991-05-14 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds |
| US4885276A (en) | 1987-06-03 | 1989-12-05 | Merck & Co., Inc. | Cyclosporin analogs with modified "C-9 amino acids" |
| EP0296123B1 (en) | 1987-06-19 | 1994-08-31 | Sandoz Ag | Cyclic peptolides |
| US5019646A (en) | 1987-08-25 | 1991-05-28 | Regents Of The University Of Minnesota | Polypeptides with fibronectin activity |
| US4914188A (en) | 1987-11-16 | 1990-04-03 | Merck & Co., Inc. | Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin |
| US4855478A (en) | 1987-11-30 | 1989-08-08 | Ici Americas Inc. | N,N'-diaryl-N-alkylureas and method of use |
| US5227492A (en) | 1988-01-20 | 1993-07-13 | Yamanouchi Pharmaceutical Co., Ltd. | Diurea derivatives useful as medicaments and processes for the preparation thereof |
| US5166429A (en) | 1988-01-20 | 1992-11-24 | Yamanouchi Pharmaceutical Co., Ltd. | Diurea derivatives useful as medicaments and processes for the preparation thereof |
| US5134121A (en) | 1988-03-28 | 1992-07-28 | Regents Of The University Of California | Nerve growth factor peptides |
| US4868210A (en) | 1988-03-30 | 1989-09-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| US5030653A (en) | 1988-03-30 | 1991-07-09 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| FR2639636B1 (fr) | 1988-11-30 | 1994-03-04 | Novapharme | Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant |
| US5187270A (en) | 1988-12-27 | 1993-02-16 | Millipore Corporation | Racemization free attachment of amino acids to a solid phase |
| US5023077A (en) | 1989-01-24 | 1991-06-11 | Aphton Corporation | Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease |
| CA2010770A1 (en) | 1989-03-09 | 1990-09-09 | Dinesh N. Khanna | Bis-n,n' nitro or amino benzoyl aminophenols |
| US4959500A (en) | 1989-05-23 | 1990-09-25 | Ethyl Corporation | Polybrominated bis sulfonamides |
| US5100899A (en) | 1989-06-06 | 1992-03-31 | Roy Calne | Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof |
| US5284826A (en) | 1989-07-24 | 1994-02-08 | Sandoz Ltd. | 0-hydroxyethyl and acyloxyethyl derivatives of [ser]8 cyclosporins |
| JPH06104651B2 (ja) | 1989-11-02 | 1994-12-21 | 株式会社ラッキー | Ｎ，ｎ’―置換ウレアの製造方法 |
| US5198582A (en) | 1989-11-02 | 1993-03-30 | Lucky Ltd. | Process for preparing symmetric N,N'-disubstituted aromatic urea |
| US5250701A (en) | 1990-02-12 | 1993-10-05 | Center For Innovative Technology | Allosteric hemoglobin modifiers which decrease oxygen affinity in blood |
| US5661182A (en) | 1990-02-12 | 1997-08-26 | Virginia Commonwealth University | Method for lowering oxygen affinity of hemoglobin in redcell suspensions, in whole blood and in vivo |
| US5432191A (en) | 1990-02-12 | 1995-07-11 | The Center For Innovative Technology | Allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| US5122511A (en) | 1990-02-27 | 1992-06-16 | Merck & Co., Inc. | Immunosuppressive cyclosporin analogs with modified amino acids at position-8 |
| FR2659982B1 (fr) | 1990-03-23 | 1995-10-20 | Serbio | Utilisation de substrats chromogenes dans la determination de candida. |
| US5198551A (en) | 1990-04-10 | 1993-03-30 | The United States Of America As Represented By The United States Department Of Energy | Polyamide thermosets |
| EP0451790A1 (de) | 1990-04-12 | 1991-10-16 | Hoechst Aktiengesellschaft | 3,5-disubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu deren Herstellung, diese enthaltende Mittel und ihre Verwendung |
| US5545719A (en) | 1990-05-01 | 1996-08-13 | Neuromedica, Inc. | Nerve growth peptides |
| DE4014655A1 (de) | 1990-05-08 | 1991-11-14 | Behringwerke Ag | Peptidamide, verfahren zu deren herstellung und diese enthaltende mittel als fibrin/thrombin-gerinnungsinhibitoren |
| US5192773A (en) | 1990-07-02 | 1993-03-09 | Vertex Pharmaceuticals, Inc. | Immunosuppressive compounds |
| US5276182A (en) | 1990-07-09 | 1994-01-04 | The Dow Chemical Company | Process for preparing polyurea oligomers |
| US5099059A (en) | 1990-08-20 | 1992-03-24 | Baker Don R | Substituted phenyl carbamates and their use as herbicides |
| US5250717A (en) | 1990-10-22 | 1993-10-05 | Ethyl Corporation | Process for preparing N,N-diarylthioureas and arylisothiocyanates |
| US5321009A (en) | 1991-04-03 | 1994-06-14 | American Home Products Corporation | Method of treating diabetes |
| US5414118A (en) | 1991-04-12 | 1995-05-09 | Asahi Kasei Kogyo Kabushiki Kaisha | Diaminourea compound and process for production thereof and high heat resistant polyurethaneurea and process for production thereof |
| AT397384B (de) | 1991-08-16 | 1994-03-25 | Chemie Linz Gmbh | Verfahren zur herstellung reiner n,n'-unsymmetrisch substituierter phenylharnstoffe |
| US5424063A (en) | 1992-01-09 | 1995-06-13 | The Dow Chemical Company | Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process |
| US5326856A (en) | 1992-04-09 | 1994-07-05 | Cytogen Corporation | Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding |
| DE4215592A1 (de) | 1992-05-12 | 1993-11-18 | Bayer Ag | Verfahren zur Herstellung von N-acylierten p-Aminophenolen |
| JPH07508005A (ja) | 1992-06-22 | 1995-09-07 | オークランド ディヴィジョン キャンサー ソサイエティ オブ ニュージーランド（インコーポレイティッド） | 細胞毒性及び抗癌活性を有するビス−（置換−フェニル）誘導体 |
| JP2782142B2 (ja) | 1992-07-23 | 1998-07-30 | カルピス株式会社 | アンジオテンシン変換酵素阻害剤及びその製造法 |
| IL106998A0 (en) | 1992-09-17 | 1993-12-28 | Univ Florida | Brain-enhanced delivery of neuroactive peptides by sequential metabolism |
| US5451677A (en) | 1993-02-09 | 1995-09-19 | Merck & Co., Inc. | Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity |
| JP3603315B2 (ja) | 1993-02-19 | 2004-12-22 | 日本製紙株式会社 | 近赤外線吸収剤およびそれを含有した熱線遮蔽材 |
| US6030991A (en) | 1993-05-20 | 2000-02-29 | Texas Biotechnology Corp. | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
| CA2123728A1 (en) | 1993-05-21 | 1994-11-22 | Noriyoshi Sueda | Urea derivatives and their use as acat inhibitors |
| US5846981A (en) | 1993-05-28 | 1998-12-08 | Gpi Nil Holdings Inc. | Inhibitors of rotamase enzyme activity |
| US5798355A (en) | 1995-06-07 | 1998-08-25 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity |
| US5464820A (en) | 1993-06-22 | 1995-11-07 | The University Hospital | Specific inhibitors of tissue kallikrein |
| JP3894949B2 (ja) | 1993-06-30 | 2007-03-22 | ザ、ウェルカム、ファンデーション、リミテッド | 抗アテローム性動脈硬化症ジアリール化合物 |
| US5534529A (en) | 1993-06-30 | 1996-07-09 | Sankyo Company, Limited | Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses |
| US5858327A (en) | 1993-09-03 | 1999-01-12 | Resolutions Pharmaceuticals, Inc. | Hydrazino-type N2 S2 radionuclide chelating compounds |
| US5576335A (en) | 1994-02-01 | 1996-11-19 | Nisshin Flour Milling Co., Ltd. | Urea derivatives and their use as ACAT inhibitors |
| US5898029A (en) | 1994-04-12 | 1999-04-27 | The John Hopkins University | Direct influences on nerve growth of agents that interact with immunophilins in combination with neurotrophic factors |
| DE4413265A1 (de) | 1994-04-16 | 1995-10-19 | Basf Ag | Hydroxyphenylharnstoffe |
| ES2138206T3 (es) * | 1994-05-31 | 2000-01-01 | Teijin Ltd | Derivados de naftaleno. |
| SE520730C2 (sv) | 1995-01-20 | 2003-08-19 | Eskil Elmer | Behandling av hjärnischemi och hjärnskador med ett neuroprotektivt läkemedel |
| US5624937A (en) | 1995-03-02 | 1997-04-29 | Eli Lilly And Company | Chemical compounds as inhibitors of amyloid beta protein production |
| GB2300187B (en) | 1995-04-28 | 1998-09-02 | Hodogaya Chemical Co Ltd | Cure-accelerator for epoxy resin |
| US5612378A (en) | 1995-06-06 | 1997-03-18 | 3-Dimensional Pharmaceuticals, Inc. | Bis-arylsulfonylaminobenzamide derivatives and the use thereof as factor Xa inhibitors |
| US5559150A (en) | 1995-06-06 | 1996-09-24 | 3-Dimensional Pharmaceuticals, Inc. | N,N-disulfonylated aminobenzene carboxlic acids and the use thereof as thrombin inhibitors |
| US5741819A (en) * | 1995-06-07 | 1998-04-21 | 3-Dimensional Pharmaceuticals, Inc. | Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors |
| US5614547A (en) | 1995-06-07 | 1997-03-25 | Guilford Pharmaceuticals Inc. | Small molecule inhibitors of rotamase enzyme |
| US5696135A (en) | 1995-06-07 | 1997-12-09 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth |
| US5859031A (en) | 1995-06-07 | 1999-01-12 | Gpi Nil Holdings, Inc. | Small molecule inhibitors of rotamase enzyme activity |
| GB9511694D0 (en) | 1995-06-09 | 1995-08-02 | Fujisawa Pharmaceutical Co | Benzamide derivatives |
| JP3337593B2 (ja) | 1995-06-22 | 2002-10-21 | 日本精工株式会社 | 転がり軸受用グリース組成物 |
| US5567831A (en) | 1995-08-16 | 1996-10-22 | Duguesne University Of The Holy Ghost | Non-steroidal sulfatase inhibitor compounds and their method of use |
| BR9610422A (pt) | 1995-08-30 | 1999-07-13 | Searle & Co | Derivados de meta-guanidina uréia tiouréia ou ácido aminobenzóico azacíclico como antagonistas de integrina |
| US5801197A (en) | 1995-10-31 | 1998-09-01 | Gpi Nil Holdings, Inc. | Rotamase enzyme activity inhibitors |
| JP3089350B2 (ja) | 1995-11-20 | 2000-09-18 | ギルフォード ファーマシューティカルズ インコーポレイテッド | シクロフィリンロタマーゼ活性の阻害剤 |
| CA2197364A1 (en) | 1996-02-15 | 1997-08-16 | Toshikazu Suzuki | Phenol compound and process for preparing the same |
| US6005008A (en) | 1996-02-16 | 1999-12-21 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| US5840305A (en) | 1996-03-14 | 1998-11-24 | The Picower Institute For Medical Research | Treatment of HIV-Infection by interfering with host cell cyclophilin receptor activity |
| PT889876E (pt) | 1996-03-29 | 2001-11-30 | Searle & Co | Derivados de fenilenossulfonamidas meta-substituidas |
| JP2000514049A (ja) | 1996-06-27 | 2000-10-24 | スミスクライン・ビーチャム・コーポレイション | Ｉｌ―８受容体拮抗薬 |
| US6083986A (en) | 1996-07-26 | 2000-07-04 | Icagen, Inc. | Potassium channel inhibitors |
| US5801187A (en) | 1996-09-25 | 1998-09-01 | Gpi-Nil Holdings, Inc. | Heterocyclic esters and amides |
| US5786378A (en) | 1996-09-25 | 1998-07-28 | Gpi Nil Holdings, Inc. | Heterocyclic thioesters |
| US5780484A (en) | 1996-11-13 | 1998-07-14 | Vertex Pharmaceuticals Incorporated | Methods for stimulating neurite growth with piperidine compounds |
| US5811434A (en) | 1996-11-13 | 1998-09-22 | Vertex Pharmacueticals Incorporated | Methods and compositions for stimulating neurite growth |
| US5994398A (en) | 1996-12-11 | 1999-11-30 | Elan Pharmaceuticals, Inc. | Arylsulfonamides as phospholipase A2 inhibitors |
| US5874449A (en) | 1996-12-31 | 1999-02-23 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of heterocyclic thioesters |
| US5721256A (en) | 1997-02-12 | 1998-02-24 | Gpi Nil Holdings, Inc. | Method of using neurotrophic sulfonamide compounds |
| ZA98825B (en) * | 1997-02-27 | 1998-10-19 | Guilford Pharm Inc | Method of using neurotrophic carbamates and ureas |
| US5846979A (en) | 1997-02-28 | 1998-12-08 | Gpi Nil Holdings, Inc. | N-oxides of heterocyclic esters, amides, thioesters, and ketones |
| US6093742A (en) | 1997-06-27 | 2000-07-25 | Vertex Pharmaceuticals, Inc. | Inhibitors of p38 |
| US6121323A (en) | 1997-12-03 | 2000-09-19 | 3M Innovative Properties Company | Bishydroxyureas |
| AU743199B2 (en) * | 1998-06-02 | 2002-01-24 | Bristol-Myers Squibb Company | Neurotrophic difluoroamide agents |
| WO2001017953A1 (en) * | 1999-09-08 | 2001-03-15 | Guilford Pharmaceuticals Inc. | Non-peptidic cyclophilin binding compounds and their use |
| US7331908B2 (en) | 2001-03-23 | 2008-02-19 | Extreme Degree Fitness, Inc. | Multi-function weight training apparatus |
| US20030005509A1 (en) | 2001-05-18 | 2003-01-09 | Kelzer Robert A. | Head gear apparatus for use with a nasal mask |
-
2002
- 2002-01-25 JP JP2002559382A patent/JP2004532187A/ja not_active Withdrawn
- 2002-01-25 CA CA002435829A patent/CA2435829A1/en not_active Abandoned
- 2002-01-25 US US10/057,203 patent/US6656971B2/en not_active Expired - Fee Related
- 2002-01-25 MX MXPA03006666A patent/MXPA03006666A/es unknown
- 2002-01-25 EP EP02706049A patent/EP1360173A2/en not_active Withdrawn
- 2002-01-25 WO PCT/US2002/002538 patent/WO2002059080A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004532187A5 (https=) | ||
| JP2004523490A5 (https=) | ||
| RU2001126559A (ru) | Активаторы глюкокиназы | |
| AR048306A1 (es) | Derivados de acidos carboxilicos aromaticos con capacidad moduladora de los niveles de insulina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de trastornos metabolicos que responden a la regulacion de gpr40 | |
| JP2021501179A5 (https=) | ||
| ES2522291T3 (es) | Agente activador para el receptor activado por el proliferador de peroxisomas | |
| RU2221796C2 (ru) | Производные аминов | |
| RU2004100839A (ru) | Производные пиперидина полезные в качестве модуляторов активности рецепторов хемокинов | |
| RU2010115574A (ru) | Замещенные амиды, фармацевтическая композиция на их основе, способ лечения заболевания, чувствительного к btk, способ повышения чувствительности раковых клеток к химиотерапии, способ уменьшения ошибок при приеме лекарства и улучшения соблюдения схемы лечения, способ ингибирования гидролиза атф, способ определения присутствия btk в образце и способ ингибирования активности в-клеток | |
| JP2008505874A5 (https=) | ||
| ATE361923T1 (de) | Derivate von n-(heteroaryl(piperidin-2- yl)methyl)benzamid, verfahren zu deren herstellung und deren anwendung in therapeutika | |
| JP2004536112A5 (https=) | ||
| JP2006518728A5 (https=) | ||
| JP2004517080A5 (https=) | ||
| JP2006077019A5 (https=) | ||
| CA2435067A1 (en) | Malonyl-coa decarboxylase inhibitors useful as metabolic modulators | |
| KR940005614A (ko) | 디페닐 옥사졸 티아졸 및 이미다졸의 아데노신 재흡수 억제 유도체 | |
| JP2004504301A5 (https=) | ||
| JP2007502806A5 (https=) | ||
| RU2001111023A (ru) | Новые производные n-(иминометил)аминов, их получение, их использование в качестве лекарственных средств и содержащие их фармацевтические композиции | |
| JP2005514334A5 (https=) | ||
| DK1682503T3 (da) | Derivater af N-(phenyl1/alkylpiperdin-2-yl)methyl)benzamid, fremstilling og anvendelse heraf inden for terapi | |
| HRP20140105T1 (hr) | Novi inhibitori seh i njihova upotreba | |
| RU2012129737A (ru) | Замещенные бензамидные производные | |
| HRP20220026T1 (hr) | Derivati izoksazola kao agonisti nuklearnog receptora i njihove uporabe |